Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

The pharmacy briefing

News & insight.

Canadian pharmacy and therapeutics news: recalls, shortages, guideline updates and developments in practice.

192 results
Medication Safety

U of T-Led BMJ Study Identifies 24 Prescribing Cascades Putting Older Adults at Risk

A BMJ study of 2.3 million Ontario seniors, led by University of Toronto and Sinai Health researchers, pinpoints 24 common "prescribing cascades" where one drug's side effect triggers an unneeded second prescription -- and calls for pharmacists to be more directly built into catching them.

Sep 13, 2026 · 4 min read Read briefing
Image: University of Toronto, Temerty Faculty of Medicine (press photo of Prof. Paula Rochon; temertymedicine.utoronto.ca/news/ontario-study-identifies-potentially-harmful-drug-combinations-prescribed-older-adults)
Drug Shortages

Dr. Reddy's Semaglutide Shortage Drags On as Generic Ozempic Struggles to Reach Pharmacies

Updated Sep 22, 2026: Health Canada now confirms Dr. Reddy's semaglutide shortage as actual (not just anticipated) and has newly listed Apotex's Apo-Semaglutide as an actual shortage too, driven by demand overflow -- meaning both approved Canadian generics are now officially short, while brand-name Ozempic remains stable.

Sep 13, 2026 · 7 min read Read briefing
Illustrative photo: an Ozempic (semaglutide) injection pen sold in China; Canadian packaging differs. Photo: HualinXMN, CC BY-SA 4.0, via Wikimedia Commons (commons.wikimedia.org/wiki/File:Ozempic®_3ml.jpg)
Practice Guidance

CPhA Highlights Canada's Role at the 84th FIP World Congress in Montréal

The Canadian Pharmacists Association reported on September 9 that Canadian pharmacy leaders played a prominent role at the 84th FIP World Congress, held in Montréal for the first time since 1997, including a session on CPhA's new National Benchmark for Pharmacy Practice. The congress drew a record 3,455 delegates from 116 countries and signals growing international attention to Canada's expanding pharmacist scope of practice.

Sep 12, 2026 · 3 min read Read briefing
Photo: congresmtl.com, CC BY-SA 2.0, via Wikimedia Commons (commons.wikimedia.org/wiki/File:Palais_des_congrès_de_Montréal_et_sa_façade_colorée_signée_Mario_Saia.jpg)
Practice Guidance

N.W.T. Drafts Regulations to Expand Pharmacist Prescribing and Vaccination Authority

The Northwest Territories is drafting new pharmacy regulations that would let pharmacists prescribe for conditions like UTIs and migraines and administer most routine vaccines, according to the territory's pharmacy association president.

Sep 12, 2026 · 3 min read Read briefing
Illustrative file photo (a pharmacist administering a vaccine, not from N.W.T.): USDA photo by Lance Cheung, public domain, via Wikimedia Commons (commons.wikimedia.org/wiki/File:COVID-19_Vaccination_(20210318-OC-LSC-0003).jpg)
Medication Safety

Teva Canada Recalls Novo-Gesic Forte Acetaminophen Lot Over Possible Foreign Material Contamination

Health Canada and Teva Canada announced the recall of one lot of Novo-Gesic Forte 500 mg acetaminophen tablets after tests found the tablets may contain phenolic resin or epoxy particles capable of injuring the digestive tract.

Sep 12, 2026 · 3 min read Read briefing
Image: Health Canada, official recall notice (recalls-rappels.canada.ca/en/alert-recall/generic-acetaminophen-teva-recalled-because-it-may-contain-foreign-material)
Regulatory Update

PEBC Ends the Pharmacist Evaluating Examination After October 2026; Alberta Sets a New Pathway for Internationally Educated Graduates

PEBC’s October 2026 sitting is the last Pharmacist Evaluating Examination; from January 2027, international pharmacy graduates with a valid document evaluation go straight to the Qualifying Examination Part I. Alberta has also replaced the CCPP bridging certificate with the University of Alberta’s Diploma in Canadian Pharmacy Practice for candidates who do not pass a qualifying exam part on the first attempt.

Sep 10, 2026 · 3 min read Read briefing
Illustrative examination setting; not a PEBC examination. Alison wood / Wikimedia Commons, CC BY 3.0. Image source
Practice Guidance

Alberta College of Pharmacy: Confirm a Provider’s Authority Before Selling Schedule 1 Drugs for Office Use

After the College of Physicians & Surgeons of Alberta reported a man allegedly presenting himself as a physician in Edmonton without a practice permit since 2015, the Alberta College of Pharmacy reminded pharmacy teams on September 8, 2026 that Schedule 1 drugs for office use may only be sold once the provider’s authority to possess them is confirmed. The reminder applies to every community pharmacy that supplies clinic stock.

Sep 10, 2026 · 2 min read Read briefing
Illustrative pharmacy dispensing; not a pharmacy or person involved. M Joko Apriyo Putro / Wikimedia Commons, CC BY-SA 4.0. Image source
Practice Guidance

NDSAC to Consider Schedule II Status for Epinephrine Nasal Spray at Its September 20 Meeting

NAPRA’s National Drug Scheduling Advisory Committee meets on September 20, 2026 to consider a request for Schedule II status for pre-filled epinephrine nasal spray devices used in anaphylaxis. If adopted by the provinces, community pharmacies would supply the device from behind the counter without a prescription.

Sep 10, 2026 · 3 min read Read briefing
Illustrative nasal spray use; not the product under review. NIAID / Wikimedia Commons, CC BY 2.0. Image source
Medication Safety

Health Canada Posts Two August Recalls of Dr. Reddy’s Semaglutide Injection: a Mislabelled Pen, Then an Impurity Across All Lots

Dr. Reddy’s Laboratories Canada recalled its Semaglutide Injection 1.34 mg/mL twice in August 2026: one lot containing a 4 mg pen labelled as 2 mg (August 12), then every lot of both DINs for an out-of-specification impurity (August 27). Community pharmacies holding the product should quarantine stock and contact patients dispensed the affected lots.

Sep 10, 2026 · 2 min read Read briefing
Illustrative injection pen; not the recalled product. Mr Hyde / Wikimedia Commons, public domain. Image source

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.